| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1
* Department of Cancer Biology,
Division of Hematology-Oncology, and
Division of Endocrinology, Diabetes and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6160, USA
1Correspondence: 612 BRB II/III, University of Pennsylvania School of Medicine, 421 Curie Blvd., Philadelphia, PA 19104-6160. E-mail: chodosh{at}mail.med.upenn.edu
Normal developmental events such as puberty, pregnancy, and parity influence the susceptibility of the mammary gland to tumorigenesis in both humans and rodent model systems. Unfortunately, constitutive transgenic mouse models that rely on mammary-specific promoters to control transgene expression have limited utility for studying the effect of developmental events on breast cancer risk since the hormonal signals governing these events also markedly influence transgene expression levels. A novel transgenic mouse system is described that uses the MMTV-LTR to drive expression of the reverse tetracycline-dependent transactivator rtTA. Transgenic mice expressing rtTA in the mammary epithelium were crossed with reporter lines bearing tet operator-controlled transgenes. We tested the ability to spatially, temporally, and quantitatively control reporter gene expression after administration of doxycycline to bitransgenic mice. Transgene expression using this system can be rapidly induced and deinduced, is highly mammary specific, can be reproducibly titrated over a wide range of expression levels, and is essentially undetectable in the uninduced state. Homogeneous transgene expression throughout the mammary epithelium can be achieved. This system permits transgene expression to be restricted to any desired stage of postnatal mammary gland development. We have developed a mammary-specific, doxycycline-inducible transgenic mouse model for studying the effect of mammary gland development on transgene-mediated phenotypes. Unlike other mammary-specific, transgenic systems that have been described, this system combines spatially homogeneous transgene expression in the mammary epithelium during puberty, pregnancy, lactation, and involution with the use of an orally administered, inexpensive, and widely available inducing agent. This system offers new opportunities for the transgenic analysis of mammary gland biology in vivo.—Gunther, E. J., Belka, G. K., Wertheim, G. B. W., Wang, J., Hartman, J. L., Boxer, R. B., Chodosh, L. A. A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology.
Key Words: transgenic mice • MMTV • transgene induction
This article has been cited by other articles:
|
|
 |
|
  Q. Shen, I. P. Uray, Y. Li, Y. Zhang, J. Hill, X.-C. Xu, M. R. Young, E. J. Gunther, S. G. Hilsenbeck, N. H. Colburn, et al. Targeting the Activator Protein 1 Transcription Factor for the Prevention of Estrogen Receptor-Negative Mammary Tumors Cancer Prevention Research, June 1, 2008; 1(1): 45 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Podsypanina, K. Politi, L. J. Beverly, and H. E. Varmus Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant Kras PNAS, April 1, 2008; 105(13): 5242 - 5247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Oakes, M. J. Naylor, M.-L. Asselin-Labat, K. D. Blazek, M. Gardiner-Garden, H. N. Hilton, M. Kazlauskas, M. A. Pritchard, L. A. Chodosh, P. L. Pfeffer, et al. The Ets transcription factor Elf5 specifies mammary alveolar cell fate Genes & Dev., March 1, 2008; 22(5): 581 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Trimboli, K. Fukino, A. de Bruin, G. Wei, L. Shen, S. M. Tanner, N. Creasap, T. J. Rosol, M. L. Robinson, C. Eng, et al. Direct Evidence for Epithelial-Mesenchymal Transitions in Breast Cancer Cancer Res., February 1, 2008; 68(3): 937 - 945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fiaschi, B. Rozell, A. Bergstrom, R. Toftgard, and M. I. Kleman Targeted Expression of GLI1 in the Mammary Gland Disrupts Pregnancy-induced Maturation and Causes Lactation Failure J. Biol. Chem., December 7, 2007; 282(49): 36090 - 36101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Bowe, A. Sadlonova, C. A. Toleman, Z. Novak, Y. Hu, P. Huang, S. Mukherjee, T. Whitsett, A. R. Frost, A. J. Paterson, et al. O-GlcNAc Integrates the Proteasome and Transcriptome To Regulate Nuclear Hormone Receptors Mol. Cell. Biol., November 15, 2006; 26(22): 8539 - 8550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Jang, R. B. Boxer, and L. A. Chodosh Isoform-Specific Ras Activation and Oncogene Dependence during MYC- and Wnt-Induced Mammary Tumorigenesis Mol. Cell. Biol., November 1, 2006; 26(21): 8109 - 8121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Vargo-Gogola, B. M. Heckman, E. J. Gunther, L. A. Chodosh, and J. M. Rosen P190-B Rho GTPase-Activating Protein Overexpression Disrupts Ductal Morphogenesis and Induces Hyperplastic Lesions in the Developing Mammary Gland Mol. Endocrinol., June 1, 2006; 20(6): 1391 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. Kues, R. Schwinzer, D. Wirth, E. Verhoeyen, E. Lemme, D. Herrmann, B. Barg-Kues, H. Hauser, K. Wonigeit, and H. Niemann Epigenetic silencing and tissue independent expression of a novel tetracycline inducible system in double-transgenic pigs FASEB J, June 1, 2006; 20(8): 1200 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Medina Mammary developmental fate and breast cancer risk Endocr. Relat. Cancer, September 1, 2005; 12(3): 483 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Welm, S. Kim, B. E. Welm, and J. M. Bishop MET and MYC cooperate in mammary tumorigenesis PNAS, March 22, 2005; 102(12): 4324 - 4329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Blakely, L. Sintasath, C. M. D'Cruz, K. T. Hahn, K. D. Dugan, G. K. Belka, and L. A. Chodosh Developmental stage determines the effects of MYC in the mammary epithelium Development, March 1, 2005; 132(5): 1147 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Frech, E. D. Halama, M. T. Tilli, B. Singh, E. J. Gunther, L. A. Chodosh, J. A. Flaws, and P. A. Furth Deregulated Estrogen Receptor {alpha} Expression in Mammary Epithelial Cells of Transgenic Mice Results in the Development of Ductal Carcinoma In situ Cancer Res., February 1, 2005; 65(3): 681 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Muraoka-Cook, N. Dumont, and C. L. Arteaga Dual Role of Transforming Growth Factor {beta} in Mammary Tumorigenesis and Metastatic Progression Clin. Cancer Res., January 15, 2005; 11(2): 937s - 943s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Muraoka-Cook, H. Kurokawa, Y. Koh, J. T. Forbes, L. R. Roebuck, M. H. Barcellos-Hoff, S. E. Moody, L. A. Chodosh, and C. L. Arteaga Conditional Overexpression of Active Transforming Growth Factor {beta}1 In vivo Accelerates Metastases of Transgenic Mammary Tumors Cancer Res., December 15, 2004; 64(24): 9002 - 9011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Li, B. Welm, K. Podsypanina, S. Huang, M. Chamorro, X. Zhang, T. Rowlands, M. Egeblad, P. Cowin, Z. Werb, et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells PNAS, December 23, 2003; 100(26): 15853 - 15858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Shigehara, C. Zaragoza, C. Kitiyakara, H. Takahashi, H. Lu, M. Moeller, L. B. Holzman, and J. B. Kopp Inducible Podocyte-Specific Gene Expression in Transgenic Mice J. Am. Soc. Nephrol., August 1, 2003; 14(8): 1998 - 2003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Schubert, X. Y. Yang, T. T.C. Yang, S. M. Factor, M. P. Lisanti, J. D. Molkentin, M. Rincon, and C.-W. Chow Requirement of transcription factor NFAT in developing atrial myocardium J. Cell Biol., June 9, 2003; 161(5): 861 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Gunther, S. E. Moody, G. K. Belka, K. T. Hahn, N. Innocent, K. D. Dugan, R. D. Cardiff, and L. A. Chodosh Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis Genes & Dev., February 15, 2003; 17(4): 488 - 501. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
